Revvity, Inc. (NYSE:RVTY) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA reduced its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 0.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 918,606 shares of the company's stock after selling 2,805 shares during the quarter. Massachusetts Financial Services Co. MA owned about 0.75% of Revvity worth $102,526,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Assetmark Inc. grew its stake in shares of Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after purchasing an additional 259 shares during the last quarter. Millstone Evans Group LLC purchased a new position in Revvity in the 4th quarter valued at $38,000. Continuum Advisory LLC increased its stake in Revvity by 2,972.7% in the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock valued at $43,000 after buying an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB raised its position in Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after buying an additional 138 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Revvity by 33.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock valued at $58,000 after acquiring an additional 131 shares in the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

RVTY has been the topic of several recent analyst reports. Raymond James reiterated an "outperform" rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Bank of America raised Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price objective on the stock in a report on Friday, December 13th. KeyCorp boosted their target price on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Barclays cut their price target on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday. Finally, Sanford C. Bernstein downgraded shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $133.75.

Remove Ads

Insiders Place Their Bets

In other news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares of the company's stock, valued at $4,232,782. This represents a 31.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.68% of the company's stock.

Revvity Price Performance

NYSE:RVTY traded down $8.72 during trading hours on Thursday, reaching $92.62. 545,613 shares of the company traded hands, compared to its average volume of 885,653. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The firm's 50-day moving average is $110.30 and its 200-day moving average is $115.59. The stock has a market cap of $11.13 billion, a P/E ratio of 41.93, a P/E/G ratio of 3.82 and a beta of 1.07. Revvity, Inc. has a 1-year low of $89.61 and a 1-year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter last year, the company earned $1.25 EPS. Equities research analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.30%. Revvity's dividend payout ratio (DPR) is presently 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.